Genome-wide DNA methylation sequencing reveals epigenetic features and potential biomarkers of Sjögren syndrome.
Ding-Qi LuXin-Yi YaoYa-Ting RenKai-Yuan ZhangXin-Chao ZhuTao HongXue YuZhi-Min XieLi-Ying ChenXin-Chang WangPublished in: International journal of rheumatic diseases (2023)
Clinical sample validation suggested that HLA class I, ADAR, and OAS2 might play a role in the development of SS. Our study shows epigenetic regulatory mechanisms and potential disease markers associated with SS, which in turn will enable us to identify new therapeutic targets.